Monoclonal antibody treatments were used less among Black, Asian, Hispanic and other race COVID-19 patients when compared to white and non-Hispanic COVID-19 patients, according to a data analysis published Jan. 21 by the CDC.
Read the full post on Becker's Hospital Review - Healthcare News
